Notes to Accounts of Medicamen Organics Ltd.

Mar 31, 2025

1. The Audited Standalone Financial Results have been reviewed by Audit Committee and approved by the Board of Directors in meeting held on 29th May 2025.

2. The Audited Standalone Financial Results are given as per the requirement of regulation 33 of the SEBI (LODR), Regulations 2015 and submiited to Stock Exchanges.

3. The Company has not revalued its Property, Plant and Equipment, therefore the company shall not required to disclose as to whether the revaluation is based on the valuation by a registeredvaluer as defined under rule 2 of the Companies (Registered Valuers and Valuation) Rules, 2017

4. Details of Loans or Advances in the nature of loans are granted to promoters, directors, KMPs and the related parties (as defined under Companies Act, 2013,) either severally or jointly with any other person, that are:

(a) repayable on demand or

(b) without specifying any terms or period of repayment

8. Contingent Liabilities:

Amount in Lakhs

Particulars

As at March 31st, 2025

As at March 31st, 2024

a. Case against the company filed by Prakash Parcel Services Ltd.

2.34

-

"b. Margin money (FDR) for Bank Guarantee on behalf of third party (Margin FDR of Rs.64,200/-)"

6.42

-

16. Micro Small and Medium Enterprises

The company has received intimation from Suppliers regarding their status under the Micro Small and Medium Enterprises Development Act, 2006, and disclosures relating to the amount unpaid as at the year-end, as required under the said Act, have been provided.

24. Unhedged Foreign Currency Outstanding payable as on 31-03-2025 is USD 67946.03 (INR 58.14 lakh).

25. Utilization of Money Raised by Public Offers and Term Loan For which they Raised and Private Placement.

a) The Company has raised ^ 10.54 Crore by way of initial public offer ("IPO") (issued 31,00,000 equity shares of ^ 10 each at a premium of ^ 24 each ) and got listed on Emerge Platform of National Stock Exchange of India Limited on June 28th, 2024. The company has utilized the amount of IPO for the purpose it was raised by the company.

b) The Company has come up with the preferential issue of 4,65,910 share warrants convertible into equivalent number of fully paid-up equity shares of face value of ^ 10/- (Rupee Ten Only) each ("Equity Shares") at the option of Allottees, in one or more tranches, within 18 (eighteen) months from the date of allotment at issue price of ^ 64.39/-. The company has utilized the amount of preferential issue for the purpose it was raised by the company.


Mar 31, 2024

k) CONTINGENT LIABILITIES

Provisions are created when there is a present obligation as a result of a past event that probably requires an outflow of resoures and reliable estimate can be made of the amount of the obligation. There is contingent liabilities of Rs. 304,180/- on account of bank guarantee issued.

l) DEFERRED TAX LIABILITIES/ASSETS

Tax Liability of the company is estimated considering the provision of Income Tax Act, 1961. Deferred Tax is recognized subject to the consideration of prudence of timing difference, being the difference between taxable incomes and accounting income that originate in one period and are capable of reversal in one or more subsequent periods.

m) EARNING PER SHARE:

Basic earnings per share is computed by dividing the net profit after tax by the number of equity shares outstanding during the period.

n) CASH & CASH EQUIVALENTS

Cash and cash equivalents comprise cash and cash on deposit with banks and corporations.

NOTE : 28 OTHER NOTES TO ACCOUNTS

1. Micro Small and Medium Enterprises

The company has received intimation from Suppliers regarding their status under the Micro Small and Medium Enterprises Development Act, 2006, and disclosures relating to the amount unpaid as at the year-end, as required under the said Act, have been provided.

2. Previous year figure has been regrouped/re-arranged wherever necessary.

3. Trade Payable, Trade Receivable & Other Parties are subject to confirmation.

4. Upon thorough examination, it has been determined that an adjustment of 104.8 Lakhs is necessary in the opening value of assets , owing to the overcharged depreciation in preceding years. This correction ensures accurate asset valuation and aligns with accounting standards, enhancing the integrity of financial reporting.

5. Expenses have been checked on test basis.

6. Related Party Disclosure

Related Party disclosures as required by Accounting Standard 18, "Related Party Disclosure", issued by the Institute of Chartered Accountants of India are given below:

See accompanying notes to the CIN:U74899DL1995PLC066416

financial statements

For N C RAJ & ASSOCIATES For and on behalf of the Board

Chartered Accountants MEDICAMEN ORGANICS LIMITED

FRN : 002249N

S/d S/d S/d

SANJAY GARG B.K. Gupta Ashutosh Gupta

(Partner) (Director) (Director)

Membership No.: 088636 DIN:00032772 DIN:00039995

UDIN : 24088636BKARJA8436

Place : New Delhi S/d S/d

Date: 16-05-2024 Lalit Gupta Varsha Bansal

(CFO) (Company Secretary)

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+